Business Description
Clearmind Medicine Inc
NAICS : 541714
SIC : 3741
ISIN : CA1850534027
Share Class Description:
CMND: Ordinary SharesCompare
Compare
Traded in other countries / regions
CMND.USACWY0.GermanyCMND.Canada IPO Date
2021-08-10Description
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 98.66 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -9.1 | |||||
| 3-Year EPS without NRI Growth Rate | -38.6 | |||||
| 3-Year FCF Growth Rate | -25.2 | |||||
| 3-Year Book Growth Rate | -59.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.09 | |||||
| 9-Day RSI | 62.94 | |||||
| 14-Day RSI | 59.79 | |||||
| 6-1 Month Momentum % | -68.17 | |||||
| 12-1 Month Momentum % | -92.69 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.96 | |||||
| Quick Ratio | 1.96 | |||||
| Cash Ratio | 1.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -205.2 | |||||
| Shareholder Yield % | -72.21 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -215.96 | |||||
| ROA % | -114.12 | |||||
| ROIC % | -220.08 | |||||
| ROC (Joel Greenblatt) % | -15922.54 | |||||
| ROCE % | -159.17 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.94 | |||||
| Price-to-Tangible-Book | 0.9 | |||||
| EV-to-EBIT | 0.97 | |||||
| EV-to-EBITDA | 0.98 | |||||
| EV-to-FCF | 1.51 | |||||
| Price-to-Net-Current-Asset-Value | 0.93 | |||||
| Price-to-Net-Cash | 1.03 | |||||
| Earnings Yield (Greenblatt) % | 103.09 | |||||
| FCF Yield % | -59.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CMND
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Clearmind Medicine Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -19.403 | ||
| Beta | 0 | ||
| Volatility % | 71.61 | ||
| 14-Day RSI | 59.79 | ||
| 14-Day ATR ($) | 0.13331 | ||
| 20-Day SMA ($) | 1.247005 | ||
| 12-1 Month Momentum % | -92.69 | ||
| 52-Week Range ($) | 0.9205 - 23.7 | ||
| Shares Outstanding (Mil) | 3.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Clearmind Medicine Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Clearmind Medicine Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Clearmind Medicine Inc Frequently Asked Questions
What is Clearmind Medicine Inc(CMND)'s stock price today?
The current price of CMND is $1.40. The 52 week high of CMND is $23.70 and 52 week low is $0.92.
When is next earnings date of Clearmind Medicine Inc(CMND)?
The next earnings date of Clearmind Medicine Inc(CMND) is 2024-06-28 Est..
Does Clearmind Medicine Inc(CMND) pay dividends? If so, how much?
Clearmind Medicine Inc(CMND) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers